No. 3

UC Irvine Health Working to Improve Precision in Breast Cancer Surgery

UC Irvine Health is officially the first institution in the country to purchase the SAVI SCOUT® surgical guidance system! UC Irvine Health comprises the clinical, medical education and research enterprises of the University of California, Irvine. The health system features Orange County’s only National Cancer Institute-designated comprehensive cancer center, high-risk perinatal/neonatal program, Level I Trauma Center and Level II Pediatric Trauma Center, and is the primary teaching hospital for the UC Irvine School of Medicine. Serving a region of more than 3 million people in Orange

County, western Riverside County and southeast Los Angeles County, UC Irvine Health and has been listed among “America’s Best Hospitals” by U.S. News & World Report for 15 consecutive years. 

Alice Police, MD, medical director of the UC Irvine Health Pacific Breast Center and assistant professor at UC Irvine, led the effort to introduce this groundbreaking technology to the UC Irvine Health system. She shares her experience using SCOUT® and it’s impact on her hospital.

What prompted you to try SCOUT?

Honestly, a hatred of wire localization was my main motivation to try SCOUT. I am always searching for a better experience for my patients, and the wire localization procedure was often described to me as the worst part of the surgery.

Did you ever consider Radioactive Seed Localization (RSL)?

No. I was never interested in RSL because of all the procedure and process issues surrounding the use of radioactive materials. SCOUT technology offered me the benefits I wanted for my patients.

How has using SCOUT improved/changed how you approach breast conserving surgery?

I now can go directly to the lesion, which results in less tissue being removed. Also, I no longer need to worry about losing clips.

How has your radiologist responded to the use of this technology?

At our breast center, we are very fortunate to have a radiologist on site allowing for us to perform same day mammography readings. My radiologist, Freddie Combs, MD is very supportive of the technology and we are working closely in these early cases. Dr. Combs has commented that in contrast to a wire placement, the procedure to place the reflector appears to be less painful for the patient.

How has SCOUT impacted your hospital’s workflow?

The most significant improvement has been more efficient patient scheduling. Since the reflector can be placed up to 7 days prior to surgery, radiology can schedule the patient during a time that best fits into their workflow, without having to perform the procedure on the same day as surgery. This allows me to start my surgical schedule earlier in the morning.
How do you see this technology benefiting patients?
The advance in surgical guidance technology is impacting my patients positively. The ease of scheduling and comfort of the system leads to less anxiety and an overall easier day of surgery for my patients.

Interested in Being a Leader in Your Community?

If you and your institution are committed to adopting new technologies to give women better breast cancer treatment options, please complete this short SAVI SCOUT Questionnaire. We promise to continue our efforts to deliver the highest level of customer service, and are proud to be offering this technology to the breast cancer community.

How Does SCOUT Work?
SAVI SCOUT surgical guidance system uses non-radioactive, wave technology similar to radar to provide real-time surgical guidance during breast surgery. The system consists of an electromagnetic wave reflective device (reflector), handpiece and console. The surgeon uses the handpiece to detect the location of the implanted reflector. The console provides real-time audible and visual indicators of the proximity of the reflector, giving surgeons a precise way to target tissue for removal.
SAVI SCOUT Surgical Guidance System



This e-newsletter is brought to you by Cianna  Medical, Inc., a women’s health company dedicated to the innovative treatment of early-stage breast cancer. As the only company dedicated exclusively to breast conservation therapy, Cianna’s commitment is to improve care and reduce the burden breast cancer treatment places on nearly 300,000 women and their loved ones each year.